Resource

 

 

 

 

 

 

 

 

 

 

 

Corporate

G+T advises Liverpool Partners consortium takeover bid for Zenitas Healthcare

11 Sep 2018

Gilbert + Tobin has advised investment group Liverpool Partners on the structuring of its share bid together with Adamantem Capital to acquire  Zenitas Healthcare (Zenitas).

The $1.46 share offer values Zenitas at about $100 million with investors signalling they are prepared to provide Zenitas with significant additional funds for future acquisitions in the competitive market of allied health and home care services.

Clifford Chance advises Samsung as part of the launch of Samsung Pay in France

11 Sep 2018

Clifford Chance has advised Samsung Electronics France in connection with the launch in France of its Samsung Pay solution for contactless payment by mobile phone, notably on aspects relating to the regulation of payment services under the new Payment Services Directive (PSD2), banking secrecy and personal data protection in the new framework laid out by the General Data Protection Regulation (GDPR).

Dentons offices in Singapore, New York and Cayman Islands collaborate on multi-jurisdictional deal advising luxury e-commerce retailer Reebonz on business combination agreement

11 Sep 2018

A multi-jurisdictional Dentons team from Singapore, New York and the Cayman Islands is advising leading Asia Pacific online luxury marketplace and platform Reebonz Limited (“Reebonz”) on its proposed business combination with Draper Oakwood Technology Acquisition, Inc (“DOTA”).

CMS advises Gilead Sciences on its agreement with Pharmstandard JSC on the production of innovative treatment for hepatitis C and HIV

07 Sep 2018

CMS Russia has advised Gilead Sciences on its localisation agreement with Pharmstandard JSC under which Pharmstandard's production facilities will be used to manufacture Gilead's medicines for treating chronic hepatitis S and HIV. This partnership will provide broad access to Gilead's proprietary innovative methods for treating these diseases to many people in Russia.

Gilead Sciences, Inc. is a research biopharmaceutical company that has been a leading innovator in the area of HIV control for over 30 years. Gilead operates in more than 35 countries around the world.

Freshfields advises KKR and Bregal Investments on the sale of Cognita to Jacobs Holding

06 Sep 2018

Freshfields Bruckhaus Deringer LLP (‘Freshfields’) has advised global private equity firms, KKR and EMK Capital, who represents Bregal Investments in relation to Cognita, on their agreement for the sale of the entire issued share capital of Cognita, the leading global schools group, to Jacobs Holding AG (‘Jacobs Holding’) of Switzerland.
 

Vedanta Enters into Revenue Sharing Contracts with the Government of India for the Exploration of Oil and Gas

05 Sep 2018

Davis Polk is advising Lazard & Co., Limited as sponsor to Vedanta Resources plc in connection with the entry by its Indian listed subsidiary, Vedanta Limited, into revenue sharing contracts with the Government of India for the exploration of oil and gas in 41 blocks in sedimentary basins throughout India pursuant to the Indian Open Acreage Licensing Policy. This is the first major auction of hydrocarbon blocks to take place in India since 2010.

Squire Patton Boggs Advises Cedar Fair in Opening of Dual-Branded Hotel for Canada’s Wonderland

05 Sep 2018

Squire Patton Boggs North American Hospitality & Leisure lead Jeff Schagren represented Cedar Fair Entertainment Company, a leader in regional amusement parks, water parks and immersive entertainment, in a successful effort to sign hotel service agreements to bring lodging to Canada’s Wonderland amusement park. The 203-room, dual-branded Hyatt Place and Hyatt House will offer both spacious guestrooms and apartment-style suites in a high-tech contemporary environment. Construction is expected to begin in the first half of 2019, with an opening date planned for late 2020.